Cara Therapeutics Inc.
CARA
|
|
| |
|
| Trading Volume | 27,722 |
|
|
2.57 - 0.24 |
| Market Cap Full | $ 19.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | 20.2% | -54.3% | -0.3% |
| Q2 | - | -65.9% | -42.4% | -24.9% |
| Q3 | - | -0.6% | -40.6% | 2.5% |
| Q4 | - | 1.1% | -54.7% | 14.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -23.8 | 50.2 | 5.1 | -22.8 | -6.7 | -51.8 | 13.2 | -0.6 | - | - | - | 22.2 |
| 2023 | |||||||||||
| 8.8 | -13 | -51.7 | -14.5 | -24.3 | -11 | 17.7 | -22.8 | -34.6 | -23.2 | -25 | -23.2 |
| 2022 | |||||||||||
| -4.9 | -10.5 | 17.2 | -25.4 | -8.9 | 10.5 | -4.3 | 18.1 | -9.3 | 0.4 | 25.5 | -9 |
| 2021 | |||||||||||
| 23.6 | -1.9 | 18.3 | -40.4 | 4.9 | 5 | -15.6 | 31 | -2.1 | 9.2 | -21.9 | -7.6 |
| 2020 | |||||||||||
| -3.5 | -5.9 | -10.7 | 12.2 | 7.1 | 7.8 | -3.9 | -5.6 | -18 | 4.2 | 10.6 | 3.1 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.5 | -0.5 | -0.5 | -0.6 |
| Q2 | -0.6 | -0.1 | -0.6 | -0.5 |
| Q3 | -0.5 | -0.4 | -0 | -0.4 |
| Q4 | 0 | -0.6 | -0.6 | 1.7 |
| A | -1.59 | -1.6 | -1.7 | 0.2 |